Genetic or Therapeutic Neutralization of ALK1 Reduces LDL Transcytosis and Atherosclerosis in Mice

Investigators showed that genetic deletion of activin-like kinase receptor (ALK1) in arterial endothelial cells of mice substantially limited low-density lipoprotein accumulation, macrophage infiltration and atherosclerosis without affecting cholesterol or triglyceride levels.
[Nature Cardiovascular Research]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News